Bharat Biotech Launches Oral Cholera Vaccine After Successful Trials

Aug 27, 2024, 07:50 AM

Bharat Biotech, an Indian vaccine manufacturer, has launched a next-generation oral cholera vaccine following successful phase 3 trials. The trials demonstrated that the vaccine is safe for public use. This development aims to address the rising global cholera cases and deaths, which have been increasing steadily since 2021. From early 2023 to March 2024, there have been 824,479 reported cases and 5,900 deaths across 31 countries. The new vaccine is expected to help bridge the global gap in cholera prevention and treatment.